The relationship between BA (bile acid) secretion (measured by GC-MS) and the expression of genes (measured by reverse transcription real-time PCR) involved in liver BA transport and metabolism was investigated at 20 and 32 weeks during rat hepatocarcinogenesis. A progressive loss of mRNA for transporters (more marked for Ntcp, Bsep and Mrp2 than for Oatp1/Oatp1a1, Oatp2/Oatp1a4 and Oatp4/Oatp1b2) was found. The mRNA levels of Cyp7a1 and the nuclear receptors FXR (farnesoid X receptor), SHP (small heterodimer partner) and FTF (α-fetoprotein transcription factor) were not modified, whereas those of Cyp8b1 were enhanced and those of Cyp27 were reduced. Biliary secretion of CA (cholic acid) remained unchanged, whereas that of CDCA (chenodeoxycholic acid) and other non-C 12 -hydroxylated BAs was diminished. The re-appearance of 'flat-BAs' (mainly allo-BAs at 20 weeks and 4 -unsaturated-BAs at 32 weeks) probably reflects the progressive decrease observed in the expression of 3-oxo-4 -steroid 5β-reductase, together with the maintenance of steroid 5α-reductase type I. A significant correlation between the 5α-reductase/5β-reductase ratio and bile output of 'flat-BAs' was found. In conclusion, during rat hepatocarcinogenesis, the expression of transporters/enzymes responsible for BA homoeostasis is changed due to mechanisms other than those controlled by FXR/SHP/FTF. These modifications result in the re-appearance of 'flat-BAs', together with an increased CA/CDCA ratio in bile.
INTRODUCTION
BA (bile acid) synthesis from cholesterol is carried out by hepatocytes. The first, and limiting, step in BA synthesis through the neutral route is mediated by the endoplasmic reticulum enzyme cholesterol 7α-hydroxylase (EC 1.14.13.17; Cyp7a1 gene; for review, see [1, 2] ). The major products of this metabolic pathway are primary BAs, CA (cholic acid) and CDCA (chenodeoxycholic acid), although CA formation also depends on the activity of sterol 12α-hydroxylase (Cyp8b1). An additional fraction of BAs is synthesized daily through the acidic pathway, whose major product is CDCA and whose first and limiting step is mediated by the mitochondrial cytochrome P-450 enzyme sterol 27-hydroxylase (EC 1.14.13.15; Cyp27).
Phenotypic changes affecting the presence and amount of BA species in the BA pool during hepatocarcinogenesis may be of pathophysiological and diagnostic/prognostic relevance [3] . Unlike major BAs, some minor BAs, including allo-BAs and 4 -unsaturated BAs, have a 'flat' structure of the steroid nucleus, similar to that of steroid hormones. These species are common in the fetal BA pool [4, 5] , but absent in adult life. However, they have been reported to re-appear in rat bile during liver regeneration [6] and carcinogenesis [7] , as well as in the plasma and the urine of patients with hepatocellular carcinoma, which has suggested a potential interest in them for the diagnosis of neoplastic liver lesions [3] .
The reason for this re-appearance remains unknown. An appealing hypothesis is that it could be accounted for by changes in the expression of key enzymes for the biotransformation of C 4 -C 5 in the steroid ring. Transformation of 3-oxo-7α-hydroxy-4-cholestene into 3-oxo-7α-hydroxy-5β-cholestane during BA synthesis is mediated by 3-oxo- 4 -steroid-5β-reductase (EC 1.3.1.23; subsequently designated as 5β-reductase). A lower rate of this metabolic process may result in an increase in the amount of 4 BAs. Supporting this hypothesis is the fact that a deficiency of 5β-reductase in children induces severe intrahepatic cholestasis [8] . In these patients, high amounts of allo-BAs in serum have been reported [8] . The presence of an active steroid-5α-reductase type I (EC 1.3.99.5; subsequently designated as 5α-reductase), an enzyme that catalyses the reduction of 4, 5 double bonds in a variety of steroid substrates, including BAs [9] , may account for the conversion of 3-oxo- 4 -steroid intermediates into their respective 3-oxo-5α-structures, and might explain the appearance of allo-BAs in children with 5β-reductase deficiency [8] .
Although other factors, such as changes in the efficiency of the liver secretory machinery or intestinal absorptive mechanisms, also play an important role, the BA pool size and composition depends, in part, on the expression of BA transporters and key enzymes involved in BA metabolism, although post-transcriptional regulation of these proteins cannot be ruled out. The aim of the present study was to investigate the existence of changes in the expression of BA transporters accounting for BA uptake/secretion by hepatocytes and key enzymes involved in major (Cyp7a1, Cyp8b1 and Cyp27) and minor 'flat' (5α-reductase and 5β-reductase) BA synthesis during rat hepatocarcinogenesis that might be involved in typical hepatocarcinogenesis-associated changes in the BA pool. The system constituted by the nuclear receptors FXR (farnesoid X receptor), SHP (small heterodimer partner) and FTF (α-fetoprotein transcription factor) is involved in the transcriptional control of several elements (enzymes and carriers) responsible for BA homoeostasis [10, 11] . Therefore the existence of changes in the steady-state mRNA levels of FXR, SHP and FTF in rat liver during hepatocarcinogenesis was also investigated.
MATERIALS AND METHODS

Chemicals
BAs and 5β-cholestane (more than 95 % pure by TLC), used as standards in GC-MS, diethylnitrosamine and 2-acetamidofluorene were purchased from Sigma-Aldrich. A mouse monoclonal antibody against α-tubulin (clone DM1A) was from Sigma-Aldrich, and a rabbit polyclonal antibody to 5α-reductase (BP806) was from Acris Antibodies. A mouse monoclonal antibody anti-GST-π (glutathione S-transferase-π ; USal-hGST-Pi-McAb-1; Alexis) was produced as described previously [12] . Antimouse or anti-rabbit IgG horseradish-peroxidase-linked antibodies and enhanced chemiluminiscence reagents were from Amersham Biosciences. All other chemicals were from Sigma-Aldrich or Merck.
Animals
Male Wistar CF rats (from maintained colonies in the animal house at the University of Salamanca, Spain) were fed on commercial pelleted rat food (Panlab) and water ad libitum. Lighting was controlled by a timer that permitted light between 08:00 and 20:00 hours. All animals received humane care as established by the Ethical Committee of the University of Salamanca, in agreement with Guide for the Care and Use of Laboratory Animals (NIH Publication no. 80-23, revised 1985) . The animals were placed in one of the following experimental groups: untreated (control) or undergoing an adaptation [13] of the protocol initially described by Solt and Farber [14] to chemically induce hepatocarcinogenesis in the rat at two different stages corresponding to 20 and 32 weeks after carcinogen administration, as reported previously [12, 13] . To carry out bile collection under sodium pentobarbital (Nembutal N. R.; Abbot) anaesthesia (50 mg/ kg of body weight, intraperitoneally), a median laparotomy was performed followed by cannulation of the common bile duct. Bile was collected in preweighed vials over the first 60 min after cannulation. At the end of the experimental period, livers were perfused with RNasefree saline, removed, weighed, immediately immersed in the RNA stabilization reagent RNAlater (Qiagen) and stored at 4
• C until RNA extraction within the following 7 days.
Determination of gene expression by real-time RT (reverse transcription)-PCR
Total RNA was isolated from liver tissue using RNAeasy spin columns (Qiagen), and was measured using the Ribo-Green RNA-Quantitation kit (Molecular Probes). An aliquot (2 µg) from extracted total RNA was subjected to RT using random nonamers and the Enhanced Avian RT-PCR kit (Genosys). Real-time quantitative PCR was performed using Amplitaq Gold polymerase (PerkinElmer) in an ABI Prism 5700 Sequence Detection System (PerkinElmer) with the following thermal conditions: a single cycle of 95
• C for 10 min, followed by 45 cycles of 95
• C for 15 s and 60
• C for 60 s. Primer oligonucleotides obtained from Genosys (Table 1) were designed with the assistance of Primer Express software (PerkinElmer) for cDNA fragments in described sequences, and their specificity was checked using BLAST. Detection was carried out using SYBR Green I. Detection of non-specific products of PCR was carried out by 2.5 % (w/v) agarose gel electrophoresis and by DNA melting temperature curves. Oligonucleotide sequence and specificity of primers used to measure mRNA levels of transporters (Ntcp, Oatp1/Oatp1a1, Oatp2/Oatp1a4, Oatp4/Oatp1b2, Bsep and Mrp2) have been reported previously [15, 16] . The results obtained from each sample were normalized using both UBQ-C (polyubiquitin C) and 18S rRNA. The latter was measured using the TaqMan ® Ribosomal RNA Control Reagents kit (PerkinElmer). Determination of absolute abundance of mRNAs was carried out using standard curves generated by fitting the log 10 of the actual amount of synthesized, purified and measured DNA template fragment (Table 1) against the Ct (threshold cycle) values, as described in detail previously [17] .
Immunoblotting studies
Liver homogenates were prepared in 250 mM sucrose, 10 mM MgCl 2 , 0.2 mM Hepes/Tris (pH 7.4) and 1 % protease inhibitor cocktail (Sigma). Preparations were denatured at 100
• C for 5 min and electrophoresed on SDS/15 % (w/v) polyacrylamide gels (50 µg of protein/ lane) under reducing conditions on a BioRad mini gel apparatus (BioRad), followed by transfer to a nitrocellulose membrane (BioRad). Blots were probed using the appropriate primary antibody. Peroxidase-linked sheep anti-mouse or donkey anti-rabbit IgG secondary antibodies were used as appropriate, and detection was accomplished by enhanced chemiluminescence. RIOD (relative integrated optical density) of the bands was calculated using NIH Image V1.62 software (National Institutes of Health).
Analytical and statistical methods
Bile flow was determined gravimetrically. After adding nordeoxycholic acid as a first internal standard, BAs from bile were enzymatically deamidated [18, 19] . Unconjugated BAs were extracted from the hydrolysate by liquidsolid extraction in C 18 cartridges (Sep-Pak; WatersMillipore). Methyl ester derivatives were prepared by reaction with ethereal diazomethane. Trimethylsilyl ether derivatives were prepared in pyridine/hexamethyldisilazane/trimethylchlorosilane (3:2:1, by vol.) for 45 min at 55
• C [20] . Prior to injection into the gas chromatograph, 5β-cholestane was added to the samples as a second internal standard. GC-MS analyses were carried out using a modification of the method described by Malavolti et al. [18] on a gas chromatograph (HP 5890 series II; Hewlett-Packard) connected to a mass spectrometer (HP 5972, Hewlett-Packard), as described previously [3] .
Results are expressed as means + − S.D. To calculate the statistical significance of differences among groups, the Student t test and the Bonferroni method of multiplerange testing were used, as appropriate.
RESULTS
Changes in the expression of hepatocyte BA transporters
To characterize the development of liver cancer in this experimental model, the abundance of GST-π protein was measured. Western blot analysis revealed that this protein was increased considerably at both 20 and 32 weeks during hepatocarcinogenesis (Figure 1 ). This paralleled the values of the relative abundance of GST-π mRNA found by RT followed by real-time quantitative PCR ( Figure 1B) . These results are in agreement with previous studies in this experimental model carried out in our laboratory using immunohistochemistry [12] , which showed the presence in liver parenchyma of encapsulated GST-π -positive tumours at 20 weeks that had already burst through the connective capsule and invaded the surrounding parenchyma by 32 weeks after carcinogen administration.
A progressive down-regulation of BA transporters, typical of differentiated hepatocytes, occurred during hepatocarcinogenesis ( Figure 2 ). This was particularly evident for the most specific transporters, i.e. Ntcp and Bsep. The expression level of Mrp2, which, among other substrates, including conjugated bilirubin, is able to transport dianionic BA derivatives, was also decreased. In contrast, the expression of less specific BA transporters, Oatp1/Oatp1a1, Oatp2/Oatp1a4, and Oatp4/Oatp1b2, was less affected by the hepatocarcinogenic process.
Changes in major BAs and related metabolic pathways
Owing to the low abundance of mRNA for some of the genes investigated, SYBR Green I instead of TaqMan ® probes was used to measure the amount of DNA amplified during real-time quantitative PCR. SYBR Green I Values are means + − S.D. Relative abundance was measured by RT, followed by real-time quantitative PCR, in total RNA obtained from rat livers from control animals (n = 9) and from animals at 20 (n = 7) and 32 (n = 7) weeks during chemically induced hepatocarcinogenesis. Comparisons among groups were carried out using the Bonferroni method of multiple-range testing.
* P < 0.05.
has the advantage of higher sensitivity, but it lacks the specificity of TaqMan ® probes. It was therefore crucial to assess the specificity of the reaction and the absence of primer-related artefacts in amplifying sequences that had not been evaluated previously as was the case for transporters [15, 16] , i.e. Cyp7a1, Cyp27 and Cyp8b1 ( Figure 3A) , GST-π (results not shown), FXR, SHP and FTF ( Figure 4A ), and 5α-reductase and 5β-reductase ( Figure 5A ). For all targeted sequences, a single amplicon was generated by PCR as indicated by the single peak seen in the DNA melting temperature curves as well as in agarose gel electrophoresis, where the bands observed in the lane corresponding to the product of PCR carried out in the presence of target DNA were of the expected size.
In agreement with previous studies in which major amidated BA species were measured by HPLC in this experimental model [12] , an impairment in total BA output (− 14 % and − 24 % at 20 and 32 weeks during hepatocarcinogenesis respectively) was observed (Table 2) , which was accompanied by a reduction in bile flow (− 23 % and − 30 % respectively). Although bile output of CA was increased by approx. 21 %, this was not enough to counterbalance the decrease in CDCA and other non-C 12 -hydroxylated-BAs (Table 2) .
Absolute abundance of the mRNAs, expressed as number of copies per 10 6 copies of 18S rRNA, was Cyp7a1 (318 + − 34) > Cyp8b1 (64 + − 12) > Cyp27 (52 + − 4), The peaks indicate the DNA melting temperature. Inset, amplified PCR products visualized in 2.5 % agarose gel electrophoresis corresponding to rat sequences for the open reading frame of the key enzymes in BA synthesis Cyp7a1, Cyp27 and Cyp8b1. Lane 1, standard DNA ladder; lane 2, negative control without the DNA template; lane 3, PCR product using as a template an aliquot of the RT reaction carried out with rat liver total RNA. (B) Relative abundance of Cyp7a1, Cyp27 and Cyp8b1 mRNA in rat liver from control animals (n = 9) and from animals at 20 (n = 7) and 32 (n = 7) weeks during chemically induced hepatocarcinogenesis. Values are means + − S.D. Comparisons among groups were carried out using the Bonferroni method of multiple-range testing.
which was consistent with the accepted relevance of the major (Cyp7a1) and alternative (Cyp27) pathways for the biosynthesis of BAs in this species. When the values of the relative abundance of mRNA in the three experimental groups were measured ( Figure 3B ), no significant change in Cyp7a1 mRNA and an increase in Cyp8b1 mRNA were observed. By contrast, the relative abundance of Cyp27 mRNA was significantly decreased at both 20 and 32 week stages. This situation probably favoured the increase in the proportion of CA in bile and the lower secretion of non-C 12 -hydroxylated-BAs during hepatocarcinogenesis ( Table 2) . As regards nuclear receptors, the relative abundances of FXR, FTF and SHP mRNAs were not significantly modified during hepatocarcinogenesis ( Figure 4B ).
Changes in 'flat-BAs' and related metabolic pathways
A very interesting change reported previously to occur in the rat BA pool during hepatocarcinogenesis is the reappearance of 'flat-BAs' [7] . In the present study, the presence of 'flat-BAs' at 20 weeks, mainly allo-BAs, and at 32 weeks, 4 -unsaturated-BAs, was confirmed (Table 2) . To investigate the cause of these changes, the expression levels of 5α-and 5β-reductase were determined. Absolute abundance of the mRNA was markedly higher for 5α-reductase (99 + − 19 copies/10 6 copies 18S rRNA) than for 5β-reductase (8 + − 2 copies/10 6 copies 18S rRNA). Moreover, the relative abundance of 5β-reductase mRNA was progressively decreased during hepatocarcinogenesis, whereas that of 5α-reductase mRNA was maintained ( Figure 5B ). This stability in the expression of 5α-reductase was confirmed by Western blotting (Figure 6 ). When the relationship between the ratio of absolute mRNA abundances for both reductases and the bile output of 'flat-BAs' was investigated, a significant correlation was found ( Figure 7 ).
DISCUSSION
At least three types of processes may be directly involved in the changes observed in BA bile output during rat hepatocarcinogenesis. (i) On one hand, modified liver cells may undergo profound phenotypic changes, leading to a loss of differentiation, which may result in modifications in the expression patterns of transporters/enzymes such as those involved in BA homoeostasis, these changing to a pattern closer to that of immature hepatocytes than that of adult cells.
(ii) Moreover, this situation is not incompatible with that associated with compensatory proliferation which occurs as a response to liver injury induced by the neoplastic lesion and, indeed, it is difficult to distinguish between them. In this respect, we have also noted that, during liver regeneration, changes in the expression patterns of key enzymes in BA synthesis are related to modifications in the BA pool in such a way that this mimics the fetal and neonatal BA pool [21] . (iii) Additionally, the presence of a space-occupying lesion may cause partial obstructive cholestasis, and hence retention of BAs within the hepatocytes, thereby contributing to bile formation in the affected area. It is well known that the accumulation of BAs plays an important role in the control of the expression of both enzymes involved in BA metabolism and BA transporters [22, 23] .
Although a mild impairment in overall bile formation was indeed observed to occur in the present experimental model during hepatocarcinogenesis, this was accompanied by only a moderate reduction in BA output (Table 2 , and [12] ). This was probably due to the loss of expression of sinusoidal and canalicular BA transporters and, hence, the reduced contribution to uptake/secretion function by liver tissue undergoing loss of differentiation. However, the remnant function in healthy liver parenchyma prevents BA accumulation in the overall liver tissue. In fact, in previous studies, we have shown [7] that the amount of BAs/g of rat liver during carcinogenesis is not increased but, instead, significantly decreased.
Previous studies have also shown that the level of BAs in the nuclei of liver cells is not enhanced during hepatocarcinogenesis [7] . Although the total amount of BAs in the nuclei remains unaffected, the proportion of molecular species is strongly modified. Thus a marked decrease in the proportion of CA together with an enhancement in UDCA (ursodeoxycholic acid) in the nuclei of liver cells at 20 and 32 weeks was reported [7] . In this respect, it is interesting to mention that the decreased amount of muricholic acids found during hepatocarcinogenesis (Table 2) probably has a minor repercussion on nuclear signals, because these species, even though they are abundant in rat hepatocytes, reach the nucleus of these cells at much lower levels than the rest of the major BAs [7] .
It is well documented that BA species have different abilities to activate nuclear receptors, such as FXR [24] . At least for this nuclear receptor, the highest activation is that mediated by CDCA, whereas more hydrophilic BAs, such as CA and UDCA, are weaker ligands or have no effect respectively. Furthermore, UDCA is able to inhibit CDCA activation of FXR in a manner parallel to its ability to antagonize other CDCA-induced signalling cascades, such as that leading to apoptosis [25] . Thus an enhanced proportion of UDCA in the nucleus of normal hepatocytes would be expected to cause an up-regulation of Cyp7a1 and Cyp8b1 by lowering the BA/FXR-mediated repression of Cyp7a1 [26] and Cyp8b1 [27] . This was indeed the situation during hepatocarcinogenesis for Cyp8b1, but not for Cyp7a1, whereas Cyp27, whose expression is not believed to be controlled directly by FXR/SHP [28] , was significantly down-regulated. These findings are in agreement with the changes appearing in bile output of major BAs. Thus maintenance of the expression levels of Cyp7a1, together with down-regulation of Cyp27 and increased expression of Cyp8b1, probably accounts for the increased proportion of CA, whereas that of CDCA and other non-C 12 -hydroxylated BAs, such as α-muricholic acid, was decreased. In SHP-null mice, BAs are still able to repress Cyp7a1 and Cyp8b1, suggesting the existence of still unknown mechanisms of regulation for the expression of these enzymes [29, 30] . This is consistent with Table 2 Bile flow and BA output into rat bile during liver carcinogenesis Bile was collected for 60 min from control animals (n = 9), and animals at 20 (n = 7) and 32 (n = results of the present study indicating that mechanisms for the control of the expression of key enzymes in BA synthesis involving FXR, SHP or FTF play a minor role during hepatocarcinogenesis. The re-appearance of 'flat-BAs' in rat bile during hepatocarcinogenesis was consistent with similar findings in the BA pool of patients with hepatocellular carcinoma, which have been suggested to be of potential diagnostic/ prognostic interest [3] . The present study offers some clues to the reason for the re-appearance of these minor BAs. 'Flat-BAs', 3β-hydroxy- 4 -cholenoic acids and 3-oxo- 4 -cholenoic acids have been found in the healthy human fetal BA pool [5] and have been associated with an immature activity of hepatic 5β-reductase [31] . Therefore the loss of overall differentiation in liver parenchyma associated with hepatocarcinogenesis may be involved in the up-regulation of GST-π and the downregulation of both specific BA transporters and 5β-reductase. The marked loss of expression of 5β-reductase during hepatocarcinogenesis, while the expression levels of 5α-reductase, whose mRNA is abundant in rat liver [32] , are maintained, resulted in a changed balance between 5β-reductase and 5α-reductase in the liver. This, together with an accumulation of these unsaturated BAs, probably accounts for the increased formation of 5α-cholanoic acids or allo-BAs. Allo-BAs share their flat structure with 4 -cholenoic acids. Thus, as the downregulation of 5β-reductase becomes more pronounced during hepatocarcinogenesis, the amount of 'flat-BAs' in bile becomes higher.
Owing to the ability of 4 -cholenoic acids to inhibit Bsep [33] , which is believed to be the rate-limiting step in the overall process of BA secretion into bile [34] , these BA species are potent cholestatic agents [35] . In this sense, in infants with an inborn deficiency in 5β-reductase, the accumulation of unsaturated BAs might be the cause of idiopathic neonatal hepatitis syndrome [8] . The presence of a still active 5α-reductase catalysing the conversion of 3-oxo- 4 -steroid intermediates into their respective 3-oxo-5α-structures has been invoked to explain the appearance of allo-BAs in these patients [8] . By contrast, allo-CA is not transported by Bsep, at least for the rat orthologue of this export pump [36] . As happens for flat unsaturated BAs [33] , allo-CA transport across the rat canalicular plasma membrane is probably mediated by Mrp2. This has two beneficial consequences: (i) allo-CA does not affect bile output of major BA species, and (ii) allo-CA is highly choleretic, i.e. the bile flow induced by this BA is greater than that induced by CA [36] .
Changes in the metabolic pathways for 'flat-BA' synthesis may be of pathophysiological relevance during hepatocarcinogenesis. In this respect, in addition to obstructive lesion and loss on function due to the presence of one or multiple tumours in the liver and the loss of expression of BA transporters, including Bsep and Mrp2, the progressive accumulation of cholestatic unsaturated BA species would potentially contribute to impair normal generation of bile flow. However, this effect could be temporally counterbalanced by biotransformation of 4 cholenoic acids into highly choleretic allo-BAs [36] . Moreover, for clinical practice, these results suggest that detection of changes in the ratio of expression levels of 5α-and 5β-reductase in liver biopsies may be of interest in the evaluation of pretumoral and tumoral liver lesions.
